Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
besifloxacin (besivance) (1 trial)
moxifloxacin (avelox) (1 trial)
Cataract (Phase 4)
Trials (1 total)
Trial APIs (2 total)